In Re: Purdue Pharma L.P.

Filing 62

ORDER: The orders of the Bankruptcy Court (Lane, U.S.B.J.), being the Thirty-Seventh Amended Order Pursuant to 11 U.S.C. § 105(a) Granting Motion for a Preliminary Injunction, dated September 6, 2024, Adv. Dkt. No. 533, the Thirty -Eighth Amended Order Pursuant to 11 U.S.C. § 105(a) Granting Motion for a Preliminary Injunction, dated September 27, 2024, Adv. Dkt. No. 557, and the Thirty-Ninth Amended Order Pursuant to 11 U.S.C. § 105(a) Granting Motion for a Preliminary Injunction, dated November 1, 2024, Adv. 0kt. No. 583, are AFFIRMED. Opinion to follow. (Signed by Judge Colleen McMahon on 11/25/2024) (sgz)

UNITED STATES DISTRICT COURT
SOUTHERN DISTRICT OF NEW YORK

- -- - -- - - - - - - - - - - - -- X
In re:

Chapter 11

PURDUE PHARMA L.P., et al.,

Case No. 19-23649 (SHL)

Debtors. 1

(Jointly Administered)
Adv. Pro. No. 19-08289
X

------------------STATE OF MARYLAND,
Appellant,

Case No. 24-Civ-7042

vs .

PURDUE PHARMA L.P. , et al.,

USDCSDNY
DOCT.Th-1.ENT
ELECTRONICALLY FILED

Appellees. 2

- -- - - -- - - - -- - - - - - - -X

DOC#:

t~

. ....LrD:_11 = [ 1

1

ORDER
The orders of the Bankruptcy Court (Lane, U.S .B.J.), being the Thirty-Seventh Amended
Order Pursuant to 11 U.S.C. § 105(a) Granting Motion for a Preliminary Injunction, dated
September 6, 2024, Adv. Dkt. No. 533 , the Thirty-Eighth Amended Order Pursuant to 11 U.S.C.

The Debtors in these cases, along with the last four digits of each Debtor' s registration number in the applicable
jurisdiction , are as follows : Purdue Pharma L.P. (74 84), Purdue Pharma Inc. (74 86), Purdue Transdermal
Technologies L.P. ( 1868), Purdue Pharma Manufacturing L.P. (3821 ), Purdue Pharmaceuticals L.P. (0034),
Imbrium Therapeutics L.P. (881 0), Ad Ion Therapeutics L.P. (6745), Greenfield Bio Ventures L.P. (6150), Seven
Seas Hill Corp. ( 45 91 ), Ophir Green Corp. (4594), Purdue Pharma of Puerto Rico (3925), Purdue Products L.P.
(4140), Purdue Pharmaceutical Products L.P. (3902), Purdue Neuroscience Company (4712), Nayatt Cove
Lifescience Inc. (7805), Button Land L.P. (7502), Rhodes Associates L.P. (N/A), Paul Land Inc. (7425), Quidnick
and L.P. (7584), Rhodes Pharmaceuticals L. P. (61 66), Rhodes Technologies (7143), UDF LP (0495), SVC
Pharma LP (571 7), and SVC Pharma Inc. (4014). The Debtors ' corporate headquarters is located at One Stamford
Forum , 20 I Tresser Boulevard, Stamford, CT 0690 I.
Appel lees in thi s case are the Debtors and the Official Committee of Unsecured Creditors of Purdue Pharma L.P.,
et al.

§ 105(a) Granting Motion for a Preliminary Injunction, dated September 27, 2024, Adv. Dkt. No.
557, and the Thirty-Ninth Amended Order Pursuant to 11 U.S.C. § 105(a) Granting Motion for a
Preliminary Inj unction, dated November 1, 2024, Adv. 0kt. No . 583 , are AFFIRMED . Opinion to
follow.

Dated: November 25, 2024

U.S.D.J .

BY ECF TO ALL COUNSEL